DrugPatentWatch Database Preview
Landela Pharm Company Profile
» See Plans and Pricing
What is the competitive landscape for LANDELA PHARM, and what generic and branded alternatives to LANDELA PHARM drugs are available?
LANDELA PHARM has three approved drugs.
Drugs and US Patents for Landela Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Landela Pharm | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 075464-002 | Jan 30, 2002 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
Landela Pharm | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 075464-001 | Jan 30, 2002 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
Landela Pharm | IPRATROPIUM BROMIDE | ipratropium bromide | SOLUTION;INHALATION | 077072-001 | Jul 19, 2005 | AN | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.